Rapid Micro Biosystems (RPID) to Release Earnings on Friday

Rapid Micro Biosystems (NASDAQ:RPID) is expected to release its Q3 2025 results before the market opens on Friday, November 7th. Analysts expect Rapid Micro Biosystems to post earnings of ($0.26) per share and revenue of $7.60 million for the quarter. Rapid Micro Biosystems has set its FY 2025 guidance at EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Friday, November 7, 2025 at 8:30 AM ET.

Rapid Micro Biosystems (NASDAQ:RPID) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.01). The company had revenue of $7.26 million during the quarter, compared to analyst estimates of $7.10 million. Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%. On average, analysts expect Rapid Micro Biosystems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Rapid Micro Biosystems Trading Up 1.4%

NASDAQ:RPID opened at $2.91 on Friday. The stock has a market capitalization of $128.65 million, a price-to-earnings ratio of -2.88 and a beta of 1.38. The firm has a fifty day simple moving average of $3.03 and a two-hundred day simple moving average of $3.11. Rapid Micro Biosystems has a 12 month low of $0.87 and a 12 month high of $4.50.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in RPID. American Century Companies Inc. lifted its stake in shares of Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after buying an additional 5,341 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Rapid Micro Biosystems in the second quarter valued at $144,000. Finally, Geode Capital Management LLC lifted its stake in shares of Rapid Micro Biosystems by 1.6% in the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock valued at $704,000 after buying an additional 3,143 shares in the last quarter. 52.60% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. Lake Street Capital began coverage on Rapid Micro Biosystems in a research note on Monday, July 28th. They set a “buy” rating and a $8.00 price target on the stock. Finally, Wall Street Zen raised Rapid Micro Biosystems from a “sell” rating to a “hold” rating in a research note on Saturday, September 13th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.